Genomic instability: Potential contributions to tumour and normal tissue response, and second tumours, after radiotherapy

Radiotherapy and Oncology

Volumn 59, Issue 2, 2001, Pages 117-126

  Hendry, Jolyon H ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Carcinogenesis; Genomic instability; Normal tissue response; Radiotherapy; Residual injury; Tumour response

Indexed keywords

BASAL CELL NEVUS SYNDROME; CANCER; CANCER GROWTH; CANCER INCIDENCE; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RECURRENCE; CELL DEATH; CELL LINE; CELL LOSS; CHROMOSOME ABERRATION; DNA POLYMORPHISM; HUMAN; KERATINOCYTE; LATENT PERIOD; LYMPHOCYTE; METASTASIS; NONHUMAN; PRIORITY JOURNAL; RADIATION CARCINOGENESIS; RADIOSENSITIVITY; REVIEW; TISSUE REACTION; TREATMENT OUTCOME;

CELL DIVISION; DNA DAMAGE; HUMANS; MUTATION; NEOPLASMS, RADIATION-INDUCED; NEOPLASMS, SECOND PRIMARY; POLYMORPHISM, GENETIC; RADIATION INJURIES; RADIATION TOLERANCE; STEM CELLS; WOUND HEALING;

EID: 0035335950     PISSN: 01678140     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-8140(01)00285-7     Document Type: Review

References (122)

1. Abbott D.W., Thompson M.E., Robinson-Benion C., Tomlinson G., Jensen R.A., Holt J.T. BRCA1 expression restores radiation resistance in BRCA1-defective cancer cells through enhancement of transcription-coupled DNA repair. J Biol Chem. 274:(26):1999;18808-18812.
2. Allalunis-Turner M.J., Lintott L.G., Barron G.M., Day R.S. 3rd, Lees-Miller S.P. Lack of correlation between DNA-dependent protein kinase activity and tumor cell radiosensitivity. Cancer Res. 55:(22):1995;5200-5202.
3. Ando K., Koike S., Shikita M., Hayata I., Otsu H., Satoh S. Radiosensitivity of late recurrences following radiotherapy of murine fibrosarcomas. Radiat Res. 113:(2):1988;334-345.
4. Appleby J.M., Barber J.B., Levine E., et al. Absence of mutations in the ATM gene in breast cancer patients with severe responses to radiotherapy. Br J Cancer. 76:(12):1997;1546-1549.
5. Arlett C.F., Harcourt S.A. Survey of radiosensitivity in a variety of human cell strains. Cancer Res. 40:(3):1980;926-932.
6. Arlett C.F., Priestley A. Deficient recovery from potentially lethal damage in some gamma-irradiated human fibroblast cell strains. Br J Cancer Suppl. 6:1984;227-232.
7. Aszterbaum M., Rothman A., Johnson R.L., et al. Identification of mutations in the human PATCHED gene in sporadic basal cell carcinomas and in patients with the basal cell nevus syndrome. J Invest Dermatol. 110:(6):1998;885-888.
8. Athma P., Rappaport R., Swift M. Molecular genotyping shows that ataxia-telangiectasia heterozygotes are predisposed to breast cancer. Cancer Genet Cytogenet. 92:(2):1996;130-134.
9. Barber J.B., Burrill W., Spreadborough A.R., et al. Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer. Radiother Oncol. 55:(2):2000;179-186.
10. Barlow C., Hirotsune S., Paylor R., et al. Atm-deficient mice: a paradigm of ataxia telangiectasia. Cell. 86:(1):1996;159-171.
11. Baverstock K. Radiation-induced genomic instability: a paradigm-breaking phenomenon and its relevance to environmentally induced cancer. Mutat Res. 454:2000;89-109.
12. Bentzen S.M., Hendry J.H. Variability in the radiosensitivity of normal cells and tissues. Report from a workshop organised by the European Society for Therapeutic Radiology and Oncology in Edinburgh, UK, September 1998. Int J Radiat Biol. 75:(4):1999;513-517.
13. Bhatia S., Robison L.L., Oberlin O., et al. Breast cancer and other second neoplasms after childhood Hodgkin's disease. N Engl J Med. 334:(12):1996;745-751.
14. CS and Ku (p70/p80) in head and neck cancers: relationships with radiosensitivity. Int J Radiat Oncol Biol Phys. 45:(4):1999;1005-1010.
15. Bouffler S.D., Kemp C.J., Balmain A., Cox R. Spontaneous and ionizing radiation-induced chromosomal abnormalities in p53-deficient mice. Cancer Res. 55:(17):1995;3883-3889.
16. Bristow R.G., Benchimol S., Hill R.P. The p53 gene as a modifier of intrinsic radiosensitivity: implications for radiotherapy. Radiother Oncol. 40:(3):1996;197-223.
17. Bronner C.E., Baker S.M., Morrison P.T., et al. Mutation in the DNA mismatch repair gene homologue hMLH1 is associated with hereditary non-polyposis colon cancer. Nature. 368:(6468):1994;258-261.
18. Brown J.M. Consequences of the tumor bed effect for regrowth delay studies. Kallman R.F. Rodent tumor models in experimental cancer therapy. 1987;189-196 Pergamon Press, New York.
19. Brugarolas J., Jacks T. Double indemnity: p53, BRCA and cancer. p53 mutation partially rescues developmental arrest in Brca1 and Brca2 null mice, suggesting a role for familial breast cancer genes in DNA damage repair. Nat Med. 3:(7):1997;721-722.
20. Buckton K.E. Chromosome aberrations in patients treated with X-irradiation for ankylosing spondylitis. Ishihara T., Sasaki M.S. Radiation-induced chromosome damage in man. 1983;491-511 Alan R. Liss, New York.
21. Burnet N.G., Johansen J., Turesson I., Nyman J., Peacock J.H. Describing patients' normal tissue reactions: concerning the possibility of individualising radiotherapy dose prescriptions based on potential predictive assays of normal tissue radiosensitivity. Steering Committee of the BioMed2 European Union Concerted Action Programme on the Development of Predictive Tests of Normal Tissue Response to Radiation Therapy. Int J Cancer. 79:(6):1998;606-613.
22. Carlomagno F., Burnet N.G., Turesson I., et al. Comparison of DNA repair protein expression and activities between human fibroblast cell lines with different radiosensitivities. Int J Cancer. 85:2000;845-849.
23. Casares S., Ionov Y., Ge H.Y., Stanbridge E., Perucho M. The microsatellite mutator phenotype of colon cancer cells is often recessive. Oncogene. 11:(11):1995;2303-2310.
24. Chan G.L., Little J.B. Cultured diploid fibroblasts from patients with the nevoid basal cell carcinoma syndrome are hypersensitive to killing by ionizing radiation. Am J Pathol. 111:(1):1983;50-55.
25. Chan D.W., Gately D.P., Urban S., et al. Lack of correlation between ATM protein expression and tumour cell radiosensitivity. Int J Radiat Biol. 74:(2):1998;217-224.
26. Chang W.P., Little J.B. Delayed reproductive death in X-irradiated Chinese hamster ovary cells. Int J Radiat Biol. 60:(3):1991;483-496.
27. Chang W.P., Little J.B. Evidence that DNA double-strand breaks initiate the phenotype of delayed reproductive death in Chinese hamster ovary cells. Radiat Res. 131:(1):1992;53-59.
28. Chatterjee A., Hodgkiss R.J., Rojas A. Contribution of lethal mutations to excision assays for tumour cell survival. Acta Oncol. 34:(4):1995;493-498.
29. Chatterjee A., Rojas A., Hodgkiss R.J. Induction of lethal mutations in experimental tumours after single and fractionated irradiations in vivo. Int J Radiat Biol. 74:(1):1998;119-127.
30. Chen F.D., Hendry J.H. Re-irradiation of mouse skin: similarity of dose reductions for healing and macrocolony endpoints. Radiother Oncol. 11:(2):1988;153-159.
31. Cressman V.L., Backlund D.C., Hicks E.M., Gowen L.C., Godfrey V., Koller B.H. Mammary tumor formation in p53- and BRCA1-deficient mice. Cell Growth Diff. 10:(1):1999;1-10.
32. Cunlift P.N., Mann J.R., Cameron A.H., Roberts K.D., Ward H.N. Radiosensitivity in ataxia-telangiectasia. Br J Radiol. 48:(569):1975;374-376.
33. Cutler T.P., Holden C.A., MacDonald D.M. Multiple naevoid basal cell carcinoma syndrome (Gorlin's syndrome). Clin Exp Dermatol. 4:(3):1979;373-379.
34. Donaldson S.S., Hancock S.L. Second cancers after Hodgkin's disease in childhood. N Engl J Med. 334:(12):1996;792-794.
35. Dubrova Y.E., Plumb M., Gutierrez B., Boulton E., Jeffreys A.J. Transgenerational mutation by radiation. Nature. 405:(6782):2000;37.
36. Dubrova Y.E., Plumb M., Brown J., Jeffreys A.J. Radiation-induced germline instability at minisatellite loci. Int J Radiat Biol. 74:(6):1998;689-696.
37. Eng C., Ponder B.A. The role of gene mutations in the genesis of familial cancers. Fed Am Soc Exp Biol J. 7:(10):1993;910-919.
38. Eeles R. Testing for the breast cancer predisposition gene, BRCA1 (editorial). Br Med J. 313:(7057):1996;572-573.
39. Featherstone T., Taylor A.M., Harnden D.G. Studies on the radiosensitivity of cells from patients with basal cell naevus syndrome. Am J Hum Genet. 35:(1):1983;58-66.
40. Finette B.A., Homans A.C., Albertini R.J. Emergence of genetic instability in children treated for leukemia. Science. 288:(5465):2000;514-517.
41. Gorgojo L., Little J.B. Expression of lethal mutations in progeny of irradiated mammalian cells. Int J Radiat Biol. 55:(4):1989;619-630.
42. Hawkins M.M. Second primary tumors following radiotherapy for childhood cancer. Int J Radiat Oncol Biol Phys. 19:(5):1990;1297-1301.
43. Hafez M., Abd-el-Nabi S.M., el Wehedi G., Al Tonbary Y. Enhanced response to the induction of sister chromatid exchange by gamma radiation in neurofibromatosis. Cancer. 57:(10):1986;1937-1940.
44. Hendry J.H. The tolerance of mouse tails to necrosis after repeated irradiation with X rays. Br J Radiol. 51:(610):1978;808-813.
45. Hendry J.H., Cai W.B., Roberts S.A., Potten C.S. p53 deficiency sensitizes clonogenic cells to irradiation in the large but not the small intestine. Radiat Res. 148:(3):1997;254-259.
46. Hendry J.H., West C.M. Implications of delayed reproductive cell death (lethal mutations/genomic instability) for the interpretation of tissue responses. Int J Radiat Biol. 68:(4):1995;363-367.
47. Hendry J.H., Xu C.X., Testa N.G. A cellular analysis of residual hemopoietic deficiencies in mice after 4 repeated doses of 4.5 Gray X rays. Int J Radiat Oncol Biol Phys. 9:(11):1983;1641-1646.
48. Heyn R., Haeberlen V., Newton W.A., et al. Second malignant neoplasms in children treated for rhabdomyosarcoma. Intergroup Rhabdomyosarcoma Study Committee. J Clin Oncol. 11:(2):1993;262-270.
49. Hill B.T., Shellard S.A., Hosking L.K., Fichtinger-Schepman A.M., Bedford P. Enhanced DNA repair and tolerance of DNA damage associated with resistance to cis-diammine-dichloroplatinum (II) after in vitro exposure of a human teratoma cell line to fractionated X-irradiation. Int J Radiat Oncol Biol Phys. 19:(1):1990;75-83.
50. Hunter R.D., Stewart J.G. The tolerance of re-irradiation of heavily irradiated human skin. Br J Radiol. 50:(596):1977;573-575.
51. ICRP Publication 79. Genetic susceptibility to cancer. International Committee on Radiological Protection. 1998;Pergamon Press, New York.
52. International Journal of Radiation Biology 1998;74(6). Special issue on Genomic Instability.
53. Jaspers N.G., Gatti R.A., Baan C., Linssen P.C., Bootsma D. Genetic complementation analysis of ataxia telangiectasia and Nijmegen breakage syndrome: a survey of 50 patients. Cytogenet Cell Genet. 49:(4):1988;259-263.
54. Jones L.A., Scott D., Cowan R., Roberts S.A. Abnormal radiosensitivity of lymphocytes from breast cancer patients with excessive normal tissue damage after radiotherapy: chromosome aberrations after low dose-rate irradiation. Int J Radiat Biol. 67:(5):1995;519-528.
55. Kadhim M.A., Marsden S.J., Wright E.G. Radiation-induced chromosomal instability in human fibroblasts: temporal effects and the influence of radiation quality. Int J Radiat Biol. 73:(2):1998;143-148.
56. Kemp C.J., Wheldon T., Balmain A. p53-deficient mice are extremely susceptible to radiation-induced tumorigenesis. Nat Genet. 8:(1):1994;66-69.
57. Kiltie A.E., Ryan A.J., Swindell R., et al. A correlation between residual radiation-induced DNA double-strand breaks in cultured fibroblasts and late radiotherapy reactions in breast cancer patients. Radiother Oncol. 51:(1):1999;55-65.
58. Little J.B. Induction of genetic instability by ionizing radiation. CR Acad Sci III. 322:(2-3):1999;127-134.
59. Little J.B., Gorgojo L., Vetrovs H. Delayed appearance of lethal and specific gene mutations in irradiated mammalian cells. Int J Radiat Oncol Biol Phys. 19:(6):1990;1425-1429.
60. Little J.B., Nichols W.W., Troilo P., Nagasawa H., Strong L.C. Radiation sensitivity of cell strains from families with genetic disorders predisposing to radiation-induced cancer. Cancer Res. 49:(17):1989;4705-4714.
61. Lord B.I., Hoyes K.P. Hemopoietic damage and induction of leukemia in offspring due to preconception paternal irradiation from incorporated plutonium-239. Radiat Res. 152:(6 Suppl):1999;S34-S37.
62. Mackay R.I., Hendry J.H. The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability. Radiother Oncol. 50:(1):1999;67-75.
63. Malcomson R.D., Clarke A.R., Peter A., Coutts S.B., Howie S.E., Harrison D.J. Apoptosis induced by gamma-irradiation, but not CD4 ligation, of peripheral T lymphocytes in vivo is p53-dependent. J Pathol. 181:(2):1997;166-171.
64. Meadows A.T. Risk factors for second malignant neoplasms: report from the Late Effects Study Group. Bull Cancer. 75:(1):1988;125-130.
65. Mendonca M.S., Kurohara W, Antoniono R., Redpath J.L. Plating efficiency as a function of time postirradiation: evidence for the delayed expression of lethal mutations. Radiat Res. 119:(2):1989;387-393.
66. Moller H. On the recall phenomenon. Br J Dermatol. 135:(4):1996;652.
67. Moore J.V. Cytotoxic injury to cell populations of solid tumours. Potten C.S., Hendry J.H. Cytotoxic insult to tissue: effects on cell lineages. 1983;368-405 Taylor & Francis, London.
68. Morgan W.F., Murnane J.P. A role for genomic instability in cellular radioresistance? Cancer Metastasis Rev. 14:(1):1995;49-58.
69. Morten J.E., Harnden D.G., Taylor A.M. Chromosome damage in G0 X-irradiated lymphocytes from patients with hereditary retinoblastoma. Cancer Res. 41:(9 Pt 1):1981;3635-3638.
70. Mothersill C., Crean M., Lyons M., et al. Expression of delayed toxicity and lethal mutations in the progeny of human cells surviving exposure to radiation and other environmental mutagens. Int J Radiat Biol. 74:(6):1998;673-680.
71. Mothersill C., Kadhim M.A., O'Reilly S., et al. Dose- and time-response relationships for lethal mutations and chromosomal instability induced by ionizing radiation in an immortalized human keratinocyte cell line. Int J Radiat Biol. 76:(6):2000;799-806.
72. Mothersill C., Seymour C. Lethal mutations and genomic instability. Int J Radiat Biol. 71:(6):1997;751-758.
73. Nicolaides N.C., Papadopoulos N., Liu B., et al. Mutations of two PMS homologues in hereditary nonpolyposis colon cancer. Nature. 371:(6492):1994;75-80.
74. NRPB 10 No. 3. Genetic heterogeneity in the population and its implications for radiation risk. Documents of the National Radiological Protection Board, UK, 1999.
75. Oppitz U., Bernthaler U., Schindler D., et al. Sequence analysis of the ATM gene in 20 patients with RTOG grade 3 or 4 acute and/or late tissue radiation side effects. Int J Radiat Oncol Biol Phys. 44:(5):1999;981-988.
76. O'Reilly S., Mothersill C., Seymour C.B. Postirradiation expression of lethal mutations in an immortalized human keratinocyte cell line. Int J Radiat Biol. 66:(1):1994;77-83.
77. Parshad R., Price F.M., Pirollo K.F., Chang E.H., Sanford K.K. Cytogenetic response to G2-phase X irradiation in relation to DNA repair and radiosensitivity in a cancer-prone family with Li-Fraumeni syndrome. Radiat Res. 136:(2):1993;236-240.
78. Perkel V.S., Gail M.H., Lubin J., et al. Radiation-induced thyroid neoplasms: evidence for familial susceptibility factors. J Clin Endocrinol Metab. 66:(6):1988;1316-1322.
79. Ponnaiya B., Cornforth M.N., Ullrich R.L. Induction of chromosomal instability in human mammary cells by neutrons and gamma rays. Radiat Res. 147:(3):1997;288-294.
80. Potten C.S. Cell cycles in cell hierarchies. Int J Radiat Biol. 49:(2):1986;257-278.
81. Price E.A., Bourne S.L., Radbourne R., et al. Rare microsatellite polymorphisms in the DNA repair genes XRCC1, XRCC3 and XRCC5 associated with cancer in patients of varying radiosensitivity. Somat Cell Mol Genet. 23:(4):1997;237-247.
82. Qi D.Y., Hendry J.H., Testa N.G. Interactions in recovery and in residual injury from sequential treatments of mouse haemopoietic and stromal marrow cell populations, using X-rays, cyclophosphamide and busulphan. Radiother Oncol. 20:(1):1991;46-52.
83. Ramsay J., Birrell G., Lavin M. Testing for mutations of the ataxia telangiectasia gene in radiosensitive breast cancer patients. Radiother Oncol. 47:(2):1998;125-128.
84. Roarty J.D., McLean I.W., Zimmerman E. Incidence of second neoplasms in patients with bilateral retinoblastoma. Ophthalmology. 95:1988;1583-1587.
85. Roberts S.A., Spreadborough A.R., Bulman B., Barber J.B., Evans D.G., Scott D. Heritability of cellular radiosensitivity: a marker of low-penetrance predisposition genes in breast cancer? Am J Hum Genet. 65:(3):1999;784-794.
86. Russell J., Wheldon T.E., Stanton P. A radioresistant variant derived from a human neuroblastoma cell line is less prone to radiation-induced apoptosis. Cancer Res. 55:(21):1995;4915-4921.
87. Salomaa S., Holmberg K., Lindholm C., et al. Chromosomal instability in in vivo irradiated subjects. Int J Radiat Biol. 74:(6):1998;771-779.
88. Sanford K.K., Parshad R., Price F.M., Tarone R.E., Benedict W.F. Cytogenetic responses to G2 phase x-irradiation of cells from retinoblastoma patients. Cancer Genet Cytogenet. 88:(1):1996;43-48.
89. Savage J.R., Bigger T.R. Aberration distribution and chromosomally marked clones in X-irradiated skin. Evans H.J., Lloyd D.C. Mutagen-induced chromosome damage in man. 1978;155-169 University Press, Edinburgh.
90. Scott D. Chromosomal radiosensitivity, cancer predisposition and response to radiotherapy. Strahlenther Onkol. 176:(5):2000;229-234.
91. Scott D., Spreadborough A., Levine E., Roberts S.A. Genetic predisposition in breast cancer. Lancet. 344:(8934):1994;1444.
92. Seymour C.B., Mothersill C., Alper T. High yields of lethal mutations in somatic mammalian cells that survive ionizing radiation. Int J Radiat Biol. 50:(1):1986;167-179.
93. Sharan S.K., Morimatsu M., Albrecht U., et al. Embryonic lethality and radiation hypersensitivity mediated by Rad51 in mice lacking Brca2. Nature. 386:(6627):1997;804-810.
94. Shayeghi M., Seal S., Regan J., et al. Heterozygosity for mutations in the ataxia telangiectasia gene is not a major cause of radiotherapy complications in breast cancer patients. Br J Cancer. 78:(7):1998;922-927.
95. Shore R.E., Hildreth N., Woodard E., Dvoretsky P., Hempelmann L., Pasternack B. Breast cancer among women given X-ray therapy for acute postpartum mastitis. J Natl Cancer Inst. 77:(3):1986;689-696.
96. Sproston A.R., Boyle J.M., Heighway J., Birch J.M., Scott D. Fibroblasts from Li-Fraumeni patients are resistant to low dose-rate irradiation. Int J Radiat Biol. 70:(2):1996;145-150.
97. Southwick G.J., Schwartz R.A. The basal cell nevus syndrome: disasters occurring among a series of 36 patients. Cancer. 44:(6):1979;2294-2305.
98. Stewart F.A., van der Kogel A.J. Retreatment tolerance of normal tissues. Semin Radiat Oncol. 4:(2):1994;103-111.
99. Strong L.C. Genetic and environmental interactions. Cancer. 40:(4 Suppl):1977;1861-1866.
100. Strong L.C., Williams W.R. The genetic implications of long-term survival of childhood cancer. A conceptual framework. Am J Pediatr Hematol Oncol. 9:(1):1987;99-103.
101. Suzuki K, Kodama S, Watanabe M. X-ray-induced genomic instability in normal human cells and DNA repair-deficient cells. Proceedings of the 11th International Congress of Radiation Research, Dublin, 1999, pp. 492-495.
102. Sznajder L., Abrahams C., Parry D.M., Gierlowski T.C., Shore-Freedman E., Schneider A.B. Multiple schwannomas and meningiomas associated with irradiation in childhood. Arch Intern Med. 156:(16):1996;1873-1878.
103. Taalman R.D., Jaspers N.G., Scheres J.M., de Wit J., Hustinx T.W. Hypersensitivity to ionizing radiation, in vitro, in a new chromosomal breakage disorder, the Nijmegen breakage syndrome. Mutat Res. 112:(1):1983;23-32.
104. Taalman R.D., Hustinx T.W., Weemaes C.M., et al. Further delineation of the Nijmegen breakage syndrome. Am J Med Genet. 32:(3):1989;425-431.
105. Tejero C., Hendry J.H., Testa N.G. Persistent dose-dependent increases in cycling of haemopoietic precursor cells after irradiation. Cell Tissue Kinet. 21:(3):1988;201-204.
106. Thames H.D., Hendry J.H. Fractionation in radiotherapy. 1987;Taylor & Francis, London.
107. Trott K.R., Jamali M., Manti L., Teibe A. Manifestations and mechanisms of radiation-induced genomic instability in V-79 Chinese hamster cells. Int J Radiat Biol. 74:(6):1998;787-791.
108. Ullrich R.L., Ponnaiya B. Radiation-induced instability and its relation to radiation carcinogenesis. Int J Radiat Biol. 74:(6):1998;747-754.
109. Annex I. Epidemiological evaluation of radiation-induced cancer. 2000;297-450 United Nations, New York.
110. Annex G. Sources, effects and risks of ionizing radiation. 1988;United Nations, New York.
111. Varghese S., Schmidt-Ullrich R.K., Dritschilo A., Jung M. Enhanced radiation late effects and cellular radiation sensitivity in an ATM heterozygous breast cancer patient. Radiat Oncol Invest. 7:(4):1999;231-237.
112. Vegesna V., Withers H.R., McBride W.H., Holly F.E. Adriamycin-induced recall of radiation pneumonitis and epilation in lung and hair follicles of mouse. Int J Radiat Oncol Biol Phys. 23:(5):1992;977-981.
113. Vogel H., Niewisch H., Matioli G. The self renewal probability of hemopoietic stem cells. J Cell Physiol. 72:(3):1968;221-228.
114. Wang L., Cui Y., Lord B.I., et al. Gamma-ray-induced cell killing and chromosome abnormalities in the bone marrow of p53-deficient mice. Radiat Res. 146:(3):1996;259-266.
115. Weichselbaum R.R., Nove J., Little J.B. X-ray sensitivity of fifty-three human diploid fibroblast cell strains from patients with characterized genetic disorders. Cancer Res. 40:(3):1980;920-925.
116. Welsch P.L., Owens K.N., King M.-C. Insights into the functions of BRCA1 and BRCA2. Trends Genet. 16:(2):2000;69-74.
117. West C.M., Davidson S.E., Elyan S.A., et al. The intrinsic radiosensitivity of normal and tumour cells. Int J Radiat Biol. 73:(4):1998;409-413.
118. Williams K.J., Boyle J.M., Birch J.M., et al. Cell cycle arrest defect in Li-Fraumeni syndrome: a mechanism of cancer predisposition? Oncogene. 14:(3):1997;277-282.
119. Wilson C.R., Davidson S.E., Margison G.P., Jackson S.P., Hendry J.H., West C.M.L. Expression of Ku70 correlates with survival in carcinoma of the cervix. Br J Cancer. 83:2000;1702-1706.
120. Wlodek D., Hittelman W.N. The repair of double-strand DNA breaks correlates with radiosensitivity of L5178Y-S and L5178Y-R cells. Radiat Res. 112:(1):1987;146-155.
121. Wong F.L., Boice J.D. Jr., Abramson D.H., et al. Cancer incidence after retinoblastoma. Radiation dose and sarcoma risk. J Am Med Assoc. 278:(15):1997;1262-1267.
122. Woods W.G., Byrne T.D. In vitro sensitivity of normal and hereditary retinoblastoma fibroblasts to DNA-damaging agents. Cancer Res. 46:(12):1986;6305-6310.